Blog
Get the latest perspectives on real world data and evidence.
Top 3 Provisions & Top 5 Recommendations: The Inflation Reduction Act & RWD Insights
Lowering prescription drug costs and health care costs are among the goals of the Inflation Reduction Act. While changes will not take effect until 2025, what can the biopharmaceutical industry expect?
read moreMeet Maxine Fisher, PhD – Part 2
I am so happy to be working with a group of people with diverse backgrounds, professional mindset, and shared mission. The strongly unified leadership team at STATinMED has been moving toward excellence.
read moreMeet Maxine Fisher, PhD Part 1
What’s impressive now is our growing clientele within the broader healthcare arena—there are many companies outside of pharma reaching to us for insights about products, services, and providers. Data-driven business intelligence is helping healthcare.
read moreRobust, Actionable Research-Ready Claims Data
Timely resource based on index dates with ability
to track time-varying events
Patient-centric insights about treatment journey
De-identified, tokenized, HIPAA-compliant
read moreFAQs: Real-World Questions, Answered.
Want to learn more about STATinMED and the power of RWD Insights? Here we share some common questions, with answers about our data source and approach. Is your data source HIPAA-compliant? Yes, our data source is de-identified, tokenized, and meets the...
2022 Spring Newsletter
Open the door to RWE. Read our latest newsletter for highlights from the Spring conference season.
read moreTargeted Epidemiology in RWE: Purpose and Patients with Rare Disease
Study Purpose and Population Epidemiology of rare diseases is important for clinicians to consider, as prevalence and incidence inform the healthcare community about likelihood of disease within an at-risk population. Studies in epidemiology also help to support...
2022 Winter Newsletter
With access to more than 80% of the US healthcare system, we use patient-level data across all-provider types to support evidence generation needs.
read moreHow to Maximize Access Planning: From Covered Lives to Clinically Eligible
Clinically eligible lives data powered by STATinMED RWD Insights offer accurate and timely TRUE market opportunity, where detailed utilization management policies are managed, and contracts are negotiated.
read more